DexCom, Inc. (DXCM)
72.11
+1.38
(+1.95%)
USD |
NASDAQ |
Jan 21, 16:00
71.69
-0.42
(-0.58%)
After-Hours: 20:00
DexCom Market Cap: 28.12B for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 209.93B |
| BioLife Solutions, Inc. | 1.230B |
| Boston Scientific Corp. | 135.95B |
| Krystal Biotech, Inc. | 8.293B |
| Tandem Diabetes Care, Inc. | 1.406B |
Market Cap Related Metrics
| PE Ratio | 40.13 |
| PS Ratio | 6.506 |
| PEG Ratio | 5.206 |
| Price to Book Value | 10.32 |
| Price to Free Cash Flow | 27.67 |
| Price | 72.11 |
| Earnings Yield | 2.49% |
| PEGY Ratio | 5.206 |
| Operating PE Ratio | 37.78 |
| Normalized PE Ratio | 40.13 |